Qi Wang
Tongji University(CN)The University of Texas MD Anderson Cancer Center(US)The University of Texas MD Anderson Cancer Center(US)Harbin Medical University(CN)Shanxi University(CN)Capital Medical University(CN)Anhui Medical University(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Wenzhou Medical University(CN)Soochow University(CN)Third Affiliated Hospital of Guangzhou Medical University(CN)Xinjiang Institute of Materia Medica(CN)Nanjing Brain Hospital(CN)Shandong Provincial Hospital(CN)Third People's Hospital of Hangzhou(CN)Shanghai Pulmonary Hospital(CN)Jiangsu Provincial Institute of Geological Survey(CN)First Affiliated Hospital of Anhui Medical University(CN)Northern Jiangsu People's Hospital(CN)Nanjing Surveying and Mapping Research Institute (China)(CN)Institute of Hematology & Blood Diseases Hospital(CN)Beijing Ditan Hospital(CN)Shandong First Medical University(CN)Yangzhou University(CN)Nanjing Medical University(CN)Guangzhou Medical University(CN)Xinjiang University(CN)
Publications by Year
Research Areas
Lung Cancer Research Studies, Colorectal Cancer Treatments and Studies, Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, RNA modifications and cancer
Most-Cited Works
- → Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities(2021)886 cited
- → XBP1 deficiency promotes hepatocyte pyroptosis by impairing mitophagy to activate mtDNA-cGAS-STING signaling in macrophages during acute liver injury(2022)335 cited
- → STING Pathway Expression Identifies NSCLC With an Immune-Responsive Phenotype(2020)200 cited
- → Mycobacterium tuberculosis suppresses innate immunity by coopting the host ubiquitin system(2015)181 cited
- → Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC(2023)171 cited
- → MCT4-dependent lactate secretion suppresses antitumor immunity in LKB1-deficient lung adenocarcinoma(2023)157 cited